Apyx Medical Corporation (APYX) vs MaxCyte, Inc. (MXCT)
- Apyx Medical Corporation APYX 2.94 −3.92%
- MaxCyte, Inc. MXCT 1.27 −3.05%
Apyx Medical Corporation and MaxCyte, Inc. are both Medical Devices companies. Apyx Medical Corporation and MaxCyte, Inc. are of similar size ($135.2M and $128.9M). Apyx Medical Corporation grew revenue faster over the last twelve months: 24.4% against −13.2%. Apyx Medical Corporation has the higher net margin (−14.2% vs −114.8%) and the higher return on invested capital (−10.3% vs −49.2%). Across the 18 metrics below, Apyx Medical Corporation leads on 12 and MaxCyte, Inc. on 6.
Valuation
Profitability
| Metric | APYX | MXCT | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.45% | 79.23% | 57.76% |
| Operating margin | (5.50%) | (134.59%) | (15.07%) |
| Net margin | (14.16%) | (114.77%) | (14.45%) |
| Free cash flow margin | (14.93%) | (76.14%) | (3.88%) |
| Return on equity | (104.67%) | (20.39%) | (10.35%) |
| Return on assets | (14.17%) | (17.62%) | (17.26%) |
| Return on invested capital | (10.33%) | (49.23%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack